Research Presentation Sessions: Oncologic Imaging

Genito-urinary tumours

Lectures

1
Introduction by the moderator - Davide Prezzi, London / UK

Introduction by the moderator - Davide Prezzi, London / UK

02:00

2
Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases - Ricardo Donners, Basel / CH

Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases - Ricardo Donners, Basel / CH

08:00

3
Hyperpolarised 13C-pyruvate MRI as a non-invasive read-out of tumour grade in renal cell carcinoma - Stephan Ursprung, Tübingen / DE

Hyperpolarised 13C-pyruvate MRI as a non-invasive read-out of tumour grade in renal cell carcinoma - Stephan Ursprung, Tübingen / DE

08:00

4
Early reduction in spectral dual-layer detector CT parameters as favourable imaging biomarkers in patients with metastatic renal cell carcinoma - Aska Drljevic-Nielsen, Aarhus N / DK

Early reduction in spectral dual-layer detector CT parameters as favourable imaging biomarkers in patients with metastatic renal cell carcinoma - Aska Drljevic-Nielsen, Aarhus N / DK

08:00

5
Evaluation of immunotherapy response with CT histogram analysis in metastatic Renal Cell Carcinoma - Sıla Cankaya, Ankara / TR

Evaluation of immunotherapy response with CT histogram analysis in metastatic Renal Cell Carcinoma - Sıla Cankaya, Ankara / TR

08:00

6
Validation of PI-RADS v2 for detection of prostate cancer among readers with different degree of experience using US/MRI fusion guided prostate biopsy as reference standard - Jinxing Yu, Richmond / US

Validation of PI-RADS v2 for detection of prostate cancer among readers with different degree of experience using US/MRI fusion guided prostate biopsy as reference standard - Jinxing Yu, Richmond / US

08:00

7
The estimated volume index (EVI); a new practical approach for treatment response monitoring in advanced ovarian cancer patients treated with neoadjuvant chemotherapy - Eva Berardi, roma / IT

The estimated volume index (EVI); a new practical approach for treatment response monitoring in advanced ovarian cancer patients treated with neoadjuvant chemotherapy - Eva Berardi, roma / IT

08:00

8
CT radiomic based models to predict residual disease and early recurrence in primary debulked ovarian cancer - Gregorio Aluffi, Verona / IT

CT radiomic based models to predict residual disease and early recurrence in primary debulked ovarian cancer - Gregorio Aluffi, Verona / IT

08:00

9
Histogram analysis for characterisation of indeterminate adrenal nodules - Abdellatif Masmoudi, tunis / TN

Histogram analysis for characterisation of indeterminate adrenal nodules - Abdellatif Masmoudi, tunis / TN

08:00